SCHEMBL3229905

SCHEMBL3229905

CCCOC(=O)Nc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 6/20 0.67
SMN1; SMN2 Q16637 5/20 0.66
ALDH1A1 P00352 2/20 0.66
MAPK1 P28482 2/20 0.66
RAB9A P51151 5/20 0.65
NPC1 O15118 4/20 0.65
TSHR P16473 1/20 0.65
MEN1 O00255 3/20 0.63
KMT2A Q03164 3/20 0.63
RECQL P46063 1/20 0.63
LMNA P02545 3/20 0.60
NPSR1 Q6W5P4 2/20 0.60
TP53 P04637 2/20 0.60
MAPT P10636 2/20 0.60
THRB P10828 1/20 0.60
CRHBP P24387 1/20 0.57
CRHR2 Q13324 1/20 0.57
GAA P10253 1/20 0.57
HSD17B10 Q99714 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7562459 0.90 SMN1; SMN2 (0.77) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL3765824 0.89 RAB9A (0.69) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL8600999 0.88 RAB9A (0.67) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL7564873 0.87 HPGD (0.79) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL7562461 0.87 SMN1; SMN2 (0.69) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL8600460 0.86 RAB9A (0.65) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL1834100 0.86 RAB9A (0.65) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL8076542 0.86 RAB9A (0.65) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL1837292 0.86 RAB9A (0.65) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A
SCHEMBL10599124 0.86 RAB9A (0.65) HPGDSMN1; SMN2ALDH1A1MAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN claimed
CN-112898184-A Method for continuously synthesizing alicyclic carbamate 河北工业大学 2021-06-04 CN claimed
US-5079383-A With A Methylating Agent Using A Zinc Halide Catalyst MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1992-01-07 US claimed
EP-0450039-A1 DIHYDRO-1,2 OXO-2 QUINOXALINE DERIVATES, THEIR PREPARATION AND THEIR APPLICATION IN THERAPEUTICS. FABRE PIERRE COSMETIQUE (FR) 1991-10-09 EP claimed
JP-3167104-A None JP disclosed
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-12-26 US disclosed
EP-4431490-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION Asahi Kasei Kabushiki Kaisha (JP) 2024-09-18 EP disclosed
CN-118215651-A Method for producing isocyanate compound, method for producing urethane compound, method for recovering amine compound, and isocyanate composition 旭化成株式会社 2024-06-18 CN disclosed
WO-2023080257-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUNDS, METHOD FOR PRODUCING CARBAMATE COMPOUNDS, METHOD FOR RECOVERING AMINE COMPOUNDS, AND ISOCYANATE COMPOSITION 旭化成株式会社 2023-05-11 WO disclosed
CN-112020493-B Method for producing urethane and method for producing isocyanate 旭化成株式会社 2023-04-21 CN disclosed
EP-4161902-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. (US) 2023-04-12 EP disclosed
CN-113024418-B Method for synthesizing alicyclic carbamate by using isopropanol as hydrogen source 河北工业大学 2023-01-24 CN disclosed
US-4552974-A Process for producing diphenylmethane dicarbamates ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-11-12 US disclosed
US-4547322-A Method for manufacture of diphenylmethane diisocyanates ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1985-10-15 US disclosed
US-4487713-A HEAT TREATMENT WITH TITANIUM, TIN, ANTIMONY OR ZIRCONIUM COMPOUND EXXON RESEARCH & ENGINEERING CO. (US) 1984-12-11 US disclosed
EP-0123412-A1 Method for manufacture of diphenylmethane diisocyanates Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-10-31 EP disclosed
EP-0110732-A2 Process for producing diphenylmethane dicarbamates Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1984-06-13 EP disclosed
US-4328354-A Preparation of methylene-bis-phenylcarbamic acid esters and polymethylene-polyphenylcarbamic acid esters BASF AKTIENGESELLSCHAFT (DE) 1982-05-04 US disclosed
US-4081472-A CATALYTIC, FROM A CARBAMATE MITSUI TOATSU CHEMICALS INC. (JA) 1978-03-28 US disclosed
US-3938986-A ISOPROPYL N-PHENYLCARBAMATE OR ISOPROPYL N-(3-CHLOROPHENYL)CARBAMATE AND 4-CHLOROPHENYL N-METHYLCARBAMATE PPG INDUSTRIES, INC. (US) 1976-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240425448-A1 METHOD FOR PRODUCING ISOCYANATE COMPOUND, METHOD FOR PRODUCING CARBAMATE COMPOUND, METHOD FOR RECOVERING AMINE COMPOUND, AND ISOCYANATE COMPOSITION IDH3A, CA7, C9 HPGD 775/4885SMN1; SMN2 2354/4885ALDH1A1 630/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.